Matinas BioPharma Holdings Inc (MTNB)
0.6344
-0.08
(-10.65%)
USD |
NYAM |
Nov 14, 16:00
0.6306
0.00 (0.00%)
After-Hours: 20:00
Matinas BioPharma Holdings Cash from Operations (Quarterly): -3.106M for June 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -3.106M |
| March 31, 2024 | -5.769M |
| December 31, 2023 | -4.579M |
| September 30, 2023 | -4.419M |
| June 30, 2023 | -2.193M |
| March 31, 2023 | -4.087M |
| December 31, 2022 | -4.299M |
| September 30, 2022 | -4.97M |
| June 30, 2022 | -5.131M |
| March 31, 2022 | -4.756M |
| December 31, 2021 | -3.957M |
| September 30, 2021 | -5.75M |
| June 30, 2021 | -0.8647M |
| March 31, 2021 | -4.651M |
| December 31, 2020 | -4.308M |
| September 30, 2020 | -5.227M |
| June 30, 2020 | -3.169M |
| March 31, 2020 | -4.664M |
| December 31, 2019 | -4.899M |
| September 30, 2019 | -4.073M |
| June 30, 2019 | -2.097M |
| March 31, 2019 | -3.023M |
| December 31, 2018 | -2.619M |
| Date | Value |
|---|---|
| September 30, 2018 | -2.638M |
| June 30, 2018 | -2.258M |
| March 31, 2018 | -2.806M |
| December 31, 2017 | -1.915M |
| September 30, 2017 | -2.785M |
| June 30, 2017 | -3.728M |
| March 31, 2017 | -3.032M |
| December 31, 2016 | -2.116M |
| September 30, 2016 | -1.366M |
| June 30, 2016 | -1.094M |
| March 31, 2016 | -1.543M |
| December 31, 2015 | -1.117M |
| September 30, 2015 | -2.158M |
| June 30, 2015 | -2.217M |
| March 31, 2015 | -2.323M |
| December 31, 2014 | -2.416M |
| September 30, 2014 | -1.61M |
| June 30, 2014 | -1.846M |
| March 31, 2014 | -2.089M |
| December 31, 2013 | -1.666M |
| September 30, 2013 | -0.887M |
| June 30, 2013 | -0.2845M |
| March 31, 2013 | -0.1501M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-5.769M
Minimum
Mar 2024
-0.8647M
Maximum
Jun 2021
-4.253M
Average
-4.579M
Median
Dec 2023
Cash from Operations (Quarterly) Benchmarks
| Equillium Inc | 0.73M |
| Tenon Medical Inc | -2.42M |
| Alphatec Holdings Inc | -5.342M |
| Merck & Co Inc | 9.291B |
| Madrigal Pharmaceuticals Inc | -66.98M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -2.938M |
| Cash from Financing (Quarterly) | 9.189M |
| Free Cash Flow | -17.87M |
| Free Cash Flow Per Share (Quarterly) | -0.6228 |
| Free Cash Flow Yield | -625.2% |